Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)

Market Cap	9.76M +6.8%
Revenue (ttm)	9.73M +61.3%
Net Income	736.97K +108.9%
EPS	0.09 +110.3%
Shares Out	8.52M
PE Ratio	13.24
Forward PE	9.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,000
Average Volume	35,950
Open	1.095
Previous Close	1.100
Day's Range	1.095 - 1.160
52-Week Range	1.010 - 1.800
Beta	1.27
RSI	49.29
Earnings Date	Jun 26, 2026

About BIT:ERFO

Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. In addition, the company engages in development and franchising of boutique fitness centers. Laboratorio Farmaceutico Erfo S.p.A. was f...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2013
• Employees: 50
• Stock Exchange: Borsa Italiana
• Ticker Symbol: ERFO

Financial Performance

In 2025, BIT:ERFO's revenue was 9.73 million, an increase of 61.32% compared to the previous year's 6.03 million. Earnings were 736,972, an increase of 108.88%.